ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Nasal Polyps
Rhinitis
Rhinosinusitis
Chronic Obstructive Pulmonary Disease
Lung Diseases

Asthma trials near Columbus, OH, USA:

Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA (AJAX)

BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...

Enrolling
Asthma
Drug: AZD4604
Other: Placebo

Phase 2

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 158 other locations

and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...

Active, not recruiting
Asthma
Drug: BFF MDI 160/9.6 μg BID (320/19.2μg/day)
Drug: BD MDI 160 μg BID (320 μg/day)

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 103 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Active, not recruiting
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BGF MDI 320/14.4/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 318 other locations

the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...

Active, not recruiting
Asthma
Drug: BD MDI 320 μg
Drug: Open-label Symbicort TBH 320/9 μg

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 143 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 95 other locations

inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma...

Enrolling
Asthma
Drug: Salbutamol HFA-152a
Drug: Salbutamol HFA-134a

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Dublin, Ohio, United States and 100 other locations

Primary Objective-To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smellSecondary Objec...

Active, not recruiting
Asthma
Chronic Rhinosinusitis With Nasal Polyps
Drug: Omalizumab
Drug: Placebo

Phase 4

Sanofi
Sanofi

Columbus, Ohio, United States of America and 94 other locations

The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...

Enrolling
Advanced Unresectable Solid Tumor
Metastatic Solid Tumor
Drug: Toripalimab
Drug: TAB004

Phase 1

TopAlliance Biosciences

Columbus, Ohio, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems